Chief Commercial Officer · Zenas BioPharma, Inc. (ZBIO)

Orlando Oliveira

FY2024 is the first fiscal year CompBrief holds for Orlando Oliveira as a named executive officer of Zenas BioPharma; the record below is that year, complete. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2024

$5,890,940

Salary $199,625Stock awards $0Bonus $293,800

3rd of 4 named executive officers at Zenas BioPharma by FY2024 total.

4 named officers on file for Zenas BioPharma, FY2024

Orlando Oliveira’s pay file — $29

  • 1 fiscal year of pay, line by line

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Zenas BioPharma’s whole pay program stands against its peers

  • Zenas BioPharma’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on ZBIO→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 28, 2025 (DEF 14A).

Free

Get Orlando Oliveira’s full pay file as a PDF — free

More than this page: up to 10 years of Orlando’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Orlando Oliveira compensation by year

Zenas BioPharma Summary Compensation Table · the one fiscal year held
In US dollars, as Zenas BioPharma reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2024
Salary$199,625
Bonus$293,800
Stock awards$0
Option awards$5,381,043
Non-equity incentive$0
Pension and deferred compensation$0
All other$16,472
Total$5,890,940

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Zenas BioPharma, Inc. DEF 14A filed April 28, 2025, accession 0001104659-25-039765, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Zenas BioPharma, Inc. filed document, accession 0001104659-25-039765. Every figure is read from that document and cited to the page and table it appears in. Filed April 28, 2025.

Equity holdings

unvested awards at FY2024 year-end
TypeUnvested unitsValue at year-endExercise price
Option7,775—$8.77
Option410,000—$17.00

Per the Outstanding Equity Awards at Fiscal Year-End table in Zenas BioPharma, Inc.'s FY2024 proxy; value at the fiscal year-end close, as the company printed it.

Zenas BioPharma’s named executive officers, FY2024

as the company reported each
Named executive officerRoleFY2024 total
Leon MoulderFounder, Chief Executive Officer and Chairman$19,998,016
Joseph FarmerPresident and Chief Operating Officer$6,004,454
Orlando Oliveira · this pageChief Commercial Officer$5,890,940
Jennifer FoxChief Business Officer and Chief Financial Officer$4,835,306

The full Zenas BioPharma compensation record

free company brief

This page is one person within Zenas BioPharma's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Zenas BioPharma's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Orlando Oliveira's compensation dossier · One-time report. No refunds.